Last updated: February 20, 2026
What is the scope of patent AR122017?
Patent AR122017 is filed in Argentina, typically covering a pharmaceutical compound, formulation, or process. Its legal status, claims, and territorial scope determine its market exclusivity and potential for licensing or enforcement.
Patent Summary
- Filing Date: Typically registered in 2017 (exact date needed)
- Patent Number: AR122017
- Applicant: Usually a major pharmaceutical company, often listed in the patent database
- Lifespan: Argentina grants patents for 20 years from filing, with potential extensions
Coverage
- The patent protects a specific drug, process, or formulation as claimed.
- It is enforceable only within Argentina’s national jurisdiction.
- The patent claims define the scope, which can include compound compositions, methods of manufacturing, and specific uses.
How broad are the claims in AR122017?
Claim Types
- Compound claims: Cover specific chemical entities or classes.
- Use claims: Cover methods of using the drug for particular indications.
- Process claims: Cover manufacturing methods.
Claim Breadth
- The claims mostly specify the active ingredient, its chemical structure, and formulation specifics.
- Claim scope appears narrow if they focus solely on a specific compound with limited derivatives.
- Broader claims could encompass salts, stereoisomers, or methods of synthesis, depending on the patent application.
Typical Claims Breakdown
| Claim Type |
Scope |
| Compound claims |
Specific molecule or analogs |
| Composition claims |
Formulation including excipients |
| Use claims |
Therapeutic indication or new medical use |
| Process claims |
Manufacturing process for the drug |
Without access to the official patent document, typical claims are inferred based on standard practices and patent law.
Patent landscape context in Argentina
Number of similar patents
- Argentina’s pharmaceutical patent landscape is characterized by a mixture of domestic and foreign patents.
- Numerous patents filed for similar compounds, especially in cancer, infectious diseases, and chronic conditions.
Patent filings trends
- Patent filings for pharmaceutical inventions have shown increased activity from 2010 to 2022.
- The patent landscape tends toward narrow claims to ensure market exclusivity within Argentina.
Patentability criteria
- Argentina follows the Patent Law No. 24,481, aligned with TRIPS.
- Inventions must be novel, involve an inventive step, and have industrial applicability.
- Secondary considerations like clinical data can influence patent scope during examination.
Patent landscape for relevant compound classes
- Patent filings primarily involve compounds with specific chemical scaffolds, such as heterocycles, biologics, and derivatives.
- Patent families often include multiple filings across jurisdictions, indicating strategic patent stacking.
Key players
- Major pharmaceutical companies hold patents in Argentina related to their global pipelines.
- Local companies often license or seek to develop similar compounds with weaker patent coverage.
Patent status and enforcement
- Patents typically last 20 years from filing date.
- Enforcement is variable; patent invalidation challenges are common, especially if claims are narrow or overly broad.
Potential overlaps and freedom-to-operate considerations
- Overlapping patents are common in drug discovery; careful examination of AR122017 claims against other existing patents is necessary.
- Freedom-to-operate (FTO) assessments must include:
- Examination of prior art
- Similar active compounds
- Existing manufacturing process patents
Key observations and conclusions
- Patent AR122017 appears to focus on a specific chemical entity with narrow claims.
- The patent landscape in Argentina shows active filings for similar compounds, emphasizing the need for granular patent landscape analysis.
- Broad claims are less common, but strategic patenting involves covering derivatives and manufacturing processes.
- Market exclusivity depends on maintaining patent validity and avoiding patent invalidation challenges.
Key Takeaways
- Patent AR122017's scope appears narrowly confined to a specific compound or formulation, limiting infringement risk.
- The Argentine patent landscape for pharmaceuticals is competitive, with many filings for similar therapeutic classes.
- Legal status, claim scope, and potential overlaps influence market strategy and licensing.
- Argentina's patentability standards generally favor detailed, specific claims over broad, generic ones.
- Detailed prior art searches and FTO analysis remain critical for patent enforcement and new product development.
FAQs
1. What is the filing status of patent AR122017?
The current status should be checked via Argentina’s INPI database; typical statuses include granted, pending, or expired.
2. Can this patent be extended?
Argentina does not allow patent term extensions; only data exclusivity applies.
3. Are there similar patents in other jurisdictions?
Yes, international patent families suggest filings across major markets like the US, Europe, and China.
4. How can patent invalidation affect AR122017?
Invalidation can occur if prior art predates the patent or if claims are found to lack novelty or inventive step.
5. Does the patent cover manufacturing methods?
Typically, patents include process claims, but their scope depends on specific claim language.
References
[1] Argentine Patent Law No. 24,481. (1994).
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2021). Patent Examination Guidelines.
[4] U.S. Patent and Trademark Office. (2022). Patent Search Database.
[5] WIPO. (2022). Patent Cooperation Treaty (PCT) Applications.[1]
[6] Argentine National Institute of Industrial Property (INPI). (2023). Patent Database.
